platinum has been researched along with Fibrosarcoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 10 (62.50) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, K; Ehara, S; Harada, S; Ishii, K; Ito, J; Kamiya, T; Matsuyama, S; Oikawa, S; Sato, T; Sera, K; Yamazaki, H; Yokota, W | 1 |
| Fujii, S; Kariya, M; Konishi, M; Mandai, M; Nanbu, K; Suzuki, A; Tabata, Y; Takakura, K | 1 |
| Djinović, VM; Kaludjerović, GN; Miljković, D; Momcilović, M; Mostarica Stojković, M; Sabo, TJ; Trajković, V | 1 |
| Kaludjerovic, GN; Maksimovic-Ivanic, D; Mijatovic, S; Miljkovic, D; Radovic, J; Sabo, TJ; Trajkovic, V | 1 |
| Chang, MJ; Egorin, MJ; Erkmen, K; Furmanski, P; Johnson, CS; Modzelewski, RA; Reyno, LM; Vlock, DR; Yu, WD | 1 |
| Ali-Osman, F; Khokhar, AR; Kido, Y; Siddik, ZH; Yoshida, M | 1 |
| Born, R; Eichholtz-Wirth, H; Hietel, B; Reidel, G | 1 |
| Bull, JM; Siddik, ZH; Strebel, FR; Wondergem, J | 1 |
| Han, I; Huang, L; Khokhar, AR; Mori, A; Perez-Soler, R; Wu, SP | 1 |
| Haga, A; Kito, H; Nagase, H; Sato, T | 1 |
| Cemazar, M; Dolzan, V; Golouh, R; Miklavcic, D; Scancar, J; Sersa, G | 1 |
| Bartelink, H; Begg, AC; Deurloo, MJ; Kop, W; van Tellingen, O | 1 |
| Gotoh, K; Hamaguchi, N; Iga, K; Igari, Y; Ogawa, Y; Ootsu, K; Shimamoto, T; Toguchi, H | 1 |
| Herman, TS; Khandekar, VS; Korbut, TT; Pfeffer, MR; Teicher, BA | 1 |
| Alvarez Sotomayor, E; Herman, TS; Khandekar, VS; Pfeffer, MR; Teicher, BA | 1 |
| Jones, JD; Robins, AB; Taylor, DM | 1 |
16 other study(ies) available for platinum and Fibrosarcoma
| Article | Year |
|---|---|
Targeted delivery of chemotherapeutic agents using improved radiosensitive liquid core microcapsules and assessment of their antitumor effect.
Topics: Alginates; Animals; Antineoplastic Agents; Calcium; Calcium Chloride; Capsules; Carboplatin; Cobalt Radioisotopes; Colorimetry; Combined Modality Therapy; Drug Compounding; Fibrosarcoma; Glucuronic Acid; Hexuronic Acids; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Platinum; Polymers; Time Factors; Yttrium | 2009 |
In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
Topics: Animals; Antineoplastic Agents; Biological Availability; Blood Urea Nitrogen; Body Weight; Cisplatin; Delayed-Action Preparations; Drug Implants; Female; Fibrosarcoma; Gelatin; Glutaral; Hemoglobins; Hydrogels; Kinetics; Leukocyte Count; Mice; Microscopy, Electron, Scanning; Platelet Count; Platinum; Spectrophotometry, Atomic; Survival Rate; Water | 2003 |
Novel platinum(IV) complexes induce rapid tumor cell death in vitro.
Topics: Animals; Apoptosis; Astrocytoma; Brain Neoplasms; Fibrosarcoma; Humans; Mice; Necrosis; Organoplatinum Compounds; Oxidative Stress; Platinum; Tumor Cells, Cultured | 2005 |
Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Antagonism; Emodin; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fibrosarcoma; Flavonoids; Glioma; Mice; Platinum; Rats; Structure-Activity Relationship | 2005 |
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
Topics: Animals; Carboplatin; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fibrosarcoma; Interleukin-1; Mice; Mice, Inbred C3H; Platinum; Receptors, Interleukin-1; Time Factors; Tumor Cells, Cultured | 1994 |
Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin.
Topics: Animals; Cisplatin; Cross-Linking Reagents; DNA; Fibrosarcoma; Kidney Diseases; Male; Mice; Mice, Inbred C3H; Organoplatinum Compounds; Platinum | 1994 |
Transient cisplatin-resistant murine fibrosarcoma cell characterized by increased metallothionein content.
Topics: Animals; Cadmium Radioisotopes; Cell Survival; Cisplatin; Drug Resistance; Fibrosarcoma; Glutathione; Metallothionein; Mice; Platinum; Spectrometry, X-Ray Emission; Tumor Cells, Cultured | 1993 |
Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?
Topics: Anesthetics; Animals; Blood Urea Nitrogen; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Fibrosarcoma; Hypothermia, Induced; Platinum; Rats; Rats, Inbred F344; Tissue Distribution | 1993 |
In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cholesterol; Drug Carriers; Female; Fibrosarcoma; G(M1) Ganglioside; Liposomes; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organoplatinum Compounds; Phosphatidylcholines; Phosphatidylethanolamines; Platinum; Polyethylene Glycols; Solubility; Time Factors; Tissue Distribution | 1996 |
Inhibition effect of propargylglycine on human fibrosarcoma HT-1080 cell invasiveness.
Topics: Alkynes; Cadmium; Chemotaxis; Collagen; Copper; Dose-Response Relationship, Drug; Drug Combinations; Fibronectins; Fibrosarcoma; Glycine; Humans; Laminin; Metallothionein; Neoplasm Invasiveness; Platinum; Proteoglycans; Time Factors; Tumor Cells, Cultured | 1998 |
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.
Topics: Animals; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; DNA Adducts; Electric Stimulation Therapy; Female; Fibrosarcoma; Injections, Intravenous; Mice; Mice, Inbred A; Necrosis; Platinum | 1999 |
Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.
Topics: Animals; Cisplatin; Delayed-Action Preparations; Drug Implants; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Platinum; Skin Neoplasms; Time Factors | 1991 |
Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia.
Topics: Animals; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Carriers; Female; Fibrosarcoma; Hot Temperature; Hyperthermia, Induced; Liposomes; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Platinum; Tissue Distribution | 1991 |
Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Drug Screening Assays, Antitumor; Fibrosarcoma; Hydrogen-Ion Concentration; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Neutral Red; Oxazines; Phenazines; Platinum | 1990 |
Interaction of PtCl4(Fast Black)2 with hyperthermia.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Hypoxia; Cell Line; Cell Survival; Cisplatin; Diazonium Compounds; Fibrosarcoma; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Mammary Neoplasms, Experimental; Mice; Organoplatinum Compounds; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured | 1989 |
Metabolism of platinum ( 14 C)ethylenediamine dichloride in the rat.
Topics: Animals; Carbon Isotopes; Chlorides; Cytosol; Ethylenediamines; Fibrosarcoma; Half-Life; Ileum; Kidney; Liver; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Pancreas; Platinum; Radioisotopes; Rats; Rats, Inbred Strains; Subcellular Fractions; Time Factors; Transplantation, Homologous | 1973 |